BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7979243)

  • 1. 5-Lipoxygenase.
    Ford-Hutchinson AW; Gresser M; Young RN
    Annu Rev Biochem; 1994; 63():383-417. PubMed ID: 7979243
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of leukotriene biosynthesis.
    Ford-Hutchinson AW
    Ann N Y Acad Sci; 1991; 629():133-42. PubMed ID: 1952545
    [No Abstract]   [Full Text] [Related]  

  • 3. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes.
    Ford-Hutchinson AW
    Trends Pharmacol Sci; 1991 Feb; 12(2):68-70. PubMed ID: 2024291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein.
    Bell RL; Harris RR
    Clin Rev Allergy Immunol; 1999; 17(1-2):91-109. PubMed ID: 10436861
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of the production and action of leukotrienes by MK-571 and MK-886.
    Ford-Hutchinson AW
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis.
    Rådmark O; Samuelsson B
    Biochem Biophys Res Commun; 2010 May; 396(1):105-10. PubMed ID: 20494120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of leukotriene production by inhibitors of lipoxygenation.
    Garland LG; Hodgson ST
    Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():33-48. PubMed ID: 7771347
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of the biosynthesis of the sulphido-leukotrienes.
    Ford-Hutchinson AW
    Adv Exp Med Biol; 1997; 400B():841-7. PubMed ID: 9547637
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Lipoxygenase-activating protein (FLAP).
    Vickers PJ
    J Lipid Mediat Cell Signal; 1995 Oct; 12(2-3):185-94. PubMed ID: 8777565
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
    Gupta N; Nicholson DW; Ford-Hutchinson AW
    Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-lipoxygenase and FLAP.
    Peters-Golden M; Brock TG
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):99-109. PubMed ID: 12895592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in leukotriene synthase activity of the human 5-lipoxygenase by site-directed mutagenesis affecting its positional specificity.
    Schwarz K; Gerth C; Anton M; Kuhn H
    Biochemistry; 2000 Nov; 39(47):14515-21. PubMed ID: 11087405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 5-lipoxygenase-activating protein (FLAP) on substrate utilization by 5-lipoxygenase.
    Vickers PJ; Deluca C; Wong E; Abramovitz M
    Adv Exp Med Biol; 1997; 400A():145-51. PubMed ID: 9547550
    [No Abstract]   [Full Text] [Related]  

  • 14. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.
    Dixon RA; Diehl RE; Opas E; Rands E; Vickers PJ; Evans JF; Gillard JW; Miller DK
    Nature; 1990 Jan; 343(6255):282-4. PubMed ID: 2300173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular biology and regulation of 5-lipoxygenase.
    Rådmark OP
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S11-5. PubMed ID: 10673219
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-Lipoxygenase: a target for antiinflammatory drugs revisited.
    Steinhilber D
    Curr Med Chem; 1999 Jan; 6(1):71-85. PubMed ID: 9873115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-lipoxygenase: cellular biology and molecular pharmacology.
    Werz O
    Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):23-44. PubMed ID: 14561204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.
    Prasit P; Belley M; Blouin M; Brideau C; Chan C; Charleson S; Evans JF; Frenette R; Gauthier JY; Guay J
    J Lipid Mediat; 1993; 6(1-3):239-44. PubMed ID: 8357985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents.
    Jampilek J; Dolezal M; Opletalova V; Hartl J
    Curr Med Chem; 2006; 13(2):117-29. PubMed ID: 16472209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis.
    Boudreau LH; Lassalle-Claux G; Cormier M; Blanchard S; Doucet MS; Surette ME; Touaibia M
    Mediators Inflamm; 2017; 2017():6904634. PubMed ID: 28680195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.